Protocol Ledger

NCT06968845 · Phase II · RECRUITING

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

Interventional Phase II clinical trial protocol NCT06968845 sponsored by Rein Therapeutics in Respiratory and Pulmonary, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2026-02-02 Enrollment: 120 participants (ESTIMATED) Federal Source: clinicaltrials.gov/study/NCT06968845
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)120 participants (ESTIMATED)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT06968845
Protocol FieldVerified Registry Value
NCT IdentifierNCT06968845
Consolidated Lead SponsorRein Therapeutics
Therapeutic Condition CohortRespiratory and Pulmonary
Clinical Trial PhasePhase II
Overall Recruitment StatusRECRUITING
Registered Enrollment120 participants (ESTIMATED)
Registered Start Date2026-02-02
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Search related sites and sponsors in the Interactive Directory, explore Respiratory and Pulmonary Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI